刘毅, 卢苇, 刘青川, 黄正明, 梁光义, 徐必学. 含没食子酸单元的马蹄金素衍生物的合成及其抗HBV活性研究J. 药学学报, 2017,52(7): 1140-1145. doi: 10.16438/j.0513-4870.2017-0059
引用本文: 刘毅, 卢苇, 刘青川, 黄正明, 梁光义, 徐必学. 含没食子酸单元的马蹄金素衍生物的合成及其抗HBV活性研究J. 药学学报, 2017,52(7): 1140-1145. doi: 10.16438/j.0513-4870.2017-0059
LIU Yi, LU Wei, LIU Qing-chuan, HUANG Zheng-ming, LIANG Guang-yi, XU Bi-xue. Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing gallic acid moietyJ. Acta Pharmaceutica Sinica, 2017,52(7): 1140-1145. doi: 10.16438/j.0513-4870.2017-0059
Citation: LIU Yi, LU Wei, LIU Qing-chuan, HUANG Zheng-ming, LIANG Guang-yi, XU Bi-xue. Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing gallic acid moietyJ. Acta Pharmaceutica Sinica, 2017,52(7): 1140-1145. doi: 10.16438/j.0513-4870.2017-0059

含没食子酸单元的马蹄金素衍生物的合成及其抗HBV活性研究

Synthesis and anti-HBV activity evaluation of Matijin-Su derivatives containing gallic acid moiety

  • 摘要: 本文以马蹄金素(Matijin-Su,MTS)为先导化合物进行结构优化,通过加入没食子酸结构单元,设计并合成了11个新的衍生物。对所合成的目标化合物以HepG2 2.2.15细胞进行体外抗HBV活性测试,结果表明:除4a4b外,其余目标化合物均有一定的体外抗HBV活性,其中5c6c6d显示较强的抗HBV 活性,其IC50达到了6.12、8.44、9.86 μmol·L-1,说明含有没食子酸结构的马蹄金素衍生物具有进一步研究的价值。

     

    Abstract: In this study, eleven containing gallic acid moiety derivatives of Matijin-Su(MTS)were synthesized and evaluated for their anti-HBV activities in HepG2 2.2.15 cells in an effort to find novel effective anti-hepatitis B virus(HBV)agents. Compounds 5c, 6c and 6d exhibited significant anti-HBV activity with IC50 values of 6.12, 8.44 and 9.86 μmol·L-1, respectively. Incorporation of gallic acid moiety into MTS derivatives can lead to profound changes in their anti-HBV activity, and could be worth of further research.

     

/

返回文章
返回